These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29499960)

  • 1. miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis.
    Zhou L; Liu S; Han M; Ma Y; Feng S; Zhao J; Lu H; Yuan X; Cheng J
    Mol Ther Nucleic Acids; 2018 Mar; 10():91-102. PubMed ID: 29499960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway.
    Lei Y; Wang QL; Shen L; Tao YY; Liu CH
    Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):575-584. PubMed ID: 30857885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
    Sun J; Zhang H; Li L; Yu L; Fu L
    Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7.
    Yu K; Li N; Cheng Q; Zheng J; Zhu M; Bao S; Chen M; Shi G
    J Mol Med (Berl); 2018 Jan; 96(1):65-74. PubMed ID: 29051972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression.
    Wang Q; Wei S; Zhou H; Li L; Zhou S; Shi C; Shi Y; Qiu J; Lu L
    Front Cell Dev Biol; 2020; 8():513. PubMed ID: 32637414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis.
    Tao L; Wu L; Zhang W; Ma WT; Yang GY; Zhang J; Xue DY; Chen B; Liu C
    Life Sci; 2020 Jul; 253():117572. PubMed ID: 32201276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
    Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
    Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
    Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
    DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.
    Yang JJ; Tao H; Liu LP; Hu W; Deng ZY; Li J
    Inflamm Res; 2017 Apr; 66(4):341-352. PubMed ID: 28025657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of serum extracellular vesicles in liver fibrosis.
    Chen L; Chen R; Kemper S; Cong M; You H; Brigstock DR
    J Extracell Vesicles; 2018; 7(1):1461505. PubMed ID: 29696080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-654-5p Contributes to the Activation and Proliferation of Hepatic Stellate Cells by Targeting RXRα.
    Ma H; Wang X; Liu X; Wang C; Gao X; Niu J
    Front Cell Dev Biol; 2022; 10():841248. PubMed ID: 35465330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
    Yu F; Fan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
    Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
    J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.